Wallace et al., 2003 - Google Patents
The therapeutic potential of NO‐NSAIDsWallace et al., 2003
- Document ID
- 17999742282114575699
- Author
- Wallace J
- Soldato P
- Publication year
- Publication venue
- Fundamental & clinical pharmacology
External Links
Snippet
NSAIDs, including those that are selective for cyclooxygenase‐2, are among the most widely used drugs. However, these drugs produce significant side effects in the gastrointestinal and cardiorenal systems, which greatly limit their utility. In recent years, a new type of anti …
- 239000000041 non-steroidal anti-inflammatory agent 0 title abstract description 36
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wallace et al. | The therapeutic potential of NO‐NSAIDs | |
| BURGAUD et al. | Nitric oxide‐releasing drugs: a novel class of effective and safe therapeutic agents | |
| Wallace et al. | Potential cardioprotective actions of no-releasing aspirin | |
| Whittle | Gastrointestinal effects of nonsteroidal anti‐inflammatory drugs | |
| Chatterjee et al. | Gallic acid enriched fraction of Phyllanthus emblica potentiates indomethacin‐induced gastric ulcer healing via e‐NOS‐dependent pathway | |
| Gedawy et al. | Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors | |
| Fiorucci et al. | NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon | |
| Vane et al. | The mechanism of action of aspirin | |
| Wallace et al. | Markedly reduced toxicity of a hydrogen sulphide‐releasing derivative of naproxen (ATB‐346) | |
| Li et al. | GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat | |
| Fiorucci et al. | Hydrogen sulfide-based therapies: focus on H2S releasing NSAIDs | |
| Olajide et al. | Anti-inflammatory properties of Amaranthus spinosus leaf extract | |
| Chávez‐Piña et al. | Carbenoxolone gastroprotective mechanism: participation of nitric oxide/cGMP/KATP pathway in ethanol‐induced gastric injury in the rat | |
| Cuzzocrea et al. | Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat | |
| Candelario-Jalil | Nimesulide as a promising neuroprotectant in brain ischemia: new experimental evidences | |
| Magierowski et al. | Nitric oxide, afferent sensory nerves, and antioxidative enzymes in the mechanism of protection mediated by tricarbonyldichlororuthenium (II) dimer and sodium hydrosulfide against aspirin-induced gastric damage | |
| Zou et al. | Discovery of a novel ERp57 inhibitor as antiplatelet agent from Danshen (Salvia miltiorrhiza) | |
| Chan | NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management | |
| El-Medany et al. | The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats | |
| Wang et al. | Role of endogenous nitric oxide synthase inhibitor in gastric mucosal injury | |
| Chen et al. | Synthesis and biological evaluation of novel indole-2-one and 7-aza-2-oxindole derivatives as anti-inflammatory agents | |
| Bhatia et al. | Rationale Design, Synthesis, Pharmacological and In‐silico Investigation of Indole‐Functionalized Isoxazoles as Anti‐inflammatory Agents | |
| Keeble et al. | Vasorelaxant effect of nitric oxide releasing steroidal and nonsteroidal anti‐inflammatory drugs | |
| Smelly et al. | COX‐LOX inhibition: Current evidence for an emerging new therapy | |
| Fiorucci | Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future |